Yahoo · Sep 10, 2026
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
Orchestra BioMed received an upgrade from BTIG while LifeStance Health Group received a price target hike from Barclays.
LF
NASDAQ · LFST
LifeStance Health Group, Inc.
Healthcare · Medical - Care Facilities
$13.06
Down-$0.32 (-2.39%)
Updated Sep 16, 2026, 11:29 AM
SID Score
6.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.63B
- P/E ratio
- -287.34
- Dividend yield
- 0.00%
- 52-week range
- $4.77 – $13.56
- Volume
- 6.43M
- Avg. volume
- 1.9M
Price performance
LFST price history
1M range · 20 trading sessions · Daily adjusted prices
LFST closed at $13.06 after 20 trading sessions, up 5.66% for the selected period.
- Last close
- $13.06
- Period change
- +5.66%
- Period low
- $12.15
- Period high
- $13.38
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $13.32 | $13.34 | $12.705 | $13.06 | 6.43M |
| Sep 14, 2026 | $13.05 | $13.56 | $13.05 | $13.38 | 5.24M |
| Sep 11, 2026 | $13.05 | $13.28 | $12.94 | $12.97 | 7.06M |
| Sep 10, 2026 | $12.60 | $13.265 | $12.60 | $13.00 | 5.94M |
| Sep 9, 2026 | $12.61 | $12.825 | $12.38 | $12.62 | 12.52M |
| Sep 8, 2026 | $12.61 | $12.905 | $12.485 | $12.80 | 3.07M |
| Sep 4, 2026 | $12.85 | $12.9778 | $12.54 | $12.73 | 2.04M |
| Sep 3, 2026 | $12.88 | $13.09 | $12.76 | $12.83 | 4.2M |
| Sep 2, 2026 | $12.74 | $13.15 | $12.74 | $12.89 | 3.92M |
| Sep 1, 2026 | $12.27 | $12.755 | $12.27 | $12.60 | 3.47M |
| Aug 31, 2026 | $12.23 | $12.405 | $12.0419 | $12.36 | 3.45M |
| Aug 28, 2026 | $12.31 | $12.59 | $12.235 | $12.31 | 4.05M |
| Aug 27, 2026 | $12.185 | $12.485 | $12.10 | $12.30 | 2.96M |
| Aug 26, 2026 | $12.21 | $12.48 | $12.01 | $12.15 | 4.43M |
| Aug 25, 2026 | $12.19 | $12.295 | $11.915 | $12.28 | 3.62M |
| Aug 24, 2026 | $12.37 | $12.655 | $12.11 | $12.16 | 2.72M |
| Aug 21, 2026 | $12.65 | $12.72 | $12.41 | $12.47 | 2.62M |
| Aug 20, 2026 | $12.70 | $12.965 | $12.605 | $12.65 | 2.31M |
| Aug 19, 2026 | $12.70 | $12.85 | $12.43 | $12.83 | 2.64M |
| Aug 18, 2026 | $12.64 | $12.7499 | $12.33 | $12.36 | 3.52M |
Latest LFST news
The latest Smart Investors Daily articles mentioning LFST.
Stock researchCompany · Overview
LFST research
Overview
Company profile and research snapshot.
Company profile
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $8.00
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 10, 2026 | Barclays | Overweight | — |
| Sep 9, 2026 | Canaccord Genuity | Buy | — |
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 14, 2026 | JP Morgan | Neutral | — |
| Aug 7, 2026 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Yahoo · Sep 10, 2026
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
Rising oil prices and inflation worries shift the spotlight to five low-leverage stocks, with strong earnings growth & balance sheets.
Benzinga · Sep 10, 2026
Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
